RGEN
Repligen Corporation · Healthcare · Medical - Instruments & Supplies
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 126 | +8 | 40.16M | $5.47B | +16 | −7 |
| Q1 2026 | 120 | -2 | 41.26M | $4.90B | +8 | −11 |
| Q4 2025 | 122 | -3 | 43.70M | $7.16B | +1 | −3 |
| Q3 2025 | 21 | +2 | 26.22M | $3.51B | +3 | −2 |
| Q2 2025 | 17 | +1 | 26.68M | $3.32B | +2 | −1 |
| Q1 2025 | 13 | +1 | 13.27M | $1.69B | +1 | — |
| Q4 2024 | 12 | 0 | 12.86M | $1.85B | +1 | −1 |
| Q3 2024 | 11 | -3 | 9.29M | $1.38B | — | −3 |
| Q2 2024 | 14 | — | 8.37M | $1.05B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.61M | — | $580.94M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.61M | — | $580.94M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 945.16K | — | $118.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 945.16K | — | $118.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 784.07K | — | $98.84M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 784.07K | — | $98.84M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 784.07K | — | $98.84M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 784.07K | — | $98.84M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 784.07K | — | $98.84M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 756.12K | — | $95.32M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 364.55K | — | $45.96M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 364.55K | — | $45.96M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 315.05K | — | $39.71M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 213.10K | — | $26.86M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (pasif) | 204.72K | — | $25.81M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 54.73K | — | $6.90M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 50.00K | — | $6.30M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 42.20K | — | $5.32M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 17.74K | — | $2.24M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 6.37K | — | $802,876 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 3.42K | — | $431,503 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 436 pemegang, 65.14M saham, $6.86B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 5.43K lbr · $976,680
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi